<SEC-DOCUMENT>0001171843-22-004116.txt : 20220603
<SEC-HEADER>0001171843-22-004116.hdr.sgml : 20220603
<ACCEPTANCE-DATETIME>20220603091419
ACCESSION NUMBER:		0001171843-22-004116
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20220603
DATE AS OF CHANGE:		20220603

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anika Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000898437
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				043145961
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14027
		FILM NUMBER:		22993047

	BUSINESS ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730
		BUSINESS PHONE:		(781) 457-9000

	MAIL ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA THERAPEUTICS INC
		DATE OF NAME CHANGE:	19970114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA RESEARCH INC
		DATE OF NAME CHANGE:	19930309
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>defa14a_060222.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Proxy Statement Pursuant to Section 14(a) of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">the Securities Exchange Act of 1934 (Amendment
No.&nbsp;&nbsp; &#8239; )</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by the Registrant&nbsp;&#9746;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by a Party other than the Registrant&nbsp;&#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check the appropriate box:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 11%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="width: 89%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary Proxy Statement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential, for Use of the Commission Only (as permitted
    by Rule 14a-6(e)(2))</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Proxy Statement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Additional Materials</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting Material under &sect;240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="text-align: justify; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="text-align: justify; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><I></I></FONT></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>ANIKA THERAPEUTICS,
INC.</B></FONT></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><I>(Name of Registrant as Specified in Its Charter)</I></FONT></P>

<P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT> </P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt">Payment of Filing Fee (Check the appropriate
    box):</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 11%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="width: 89%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No fee required.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee paid previously with preliminary materials.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; padding-top: 12pt; padding-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Proxy Advisory Firm
ISS Recommends Vote &ldquo;FOR&rdquo;<BR>
Amendment of 2017 Omnibus Incentive Plan<BR>
at Annual Meeting of Stockholders of Anika Therapeutics</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Today the proxy advisory firm Institutional
Shareholder Services Inc. (ISS) has joined proxy advisory firm Glass Lewis &amp; Co. in recommending that stockholders vote in favor of
a proposed amendment to Anika&rsquo;s 2017 Omnibus Incentive Plan. The proposal, which will be considered at Anika&rsquo;s Annual Meeting
of Stockholders being held at 9&nbsp;a.m. (Eastern time) on June 8, 2022, would increase by 250,000 the number of shares of common stock
reserved under the incentive plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Anika encourages all stockholders of record
as of April 13, 2022 who have not yet voted, or who wish to change their previous vote, to do so prior to 11:59 PM, Eastern time, on June
7, 2022. Stockholders who have questions or need assistance in connection with voting their shares should contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Georgeson LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">1290 Avenue of the Americas,
9<SUP>th</SUP>&nbsp;Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">New York, NY 10104</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Toll Free:&nbsp;888-293-6908</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Additional Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">In connection with the Annual Meeting, Anika
filed with the Securities and Exchange Commission a Proxy Statement on April&nbsp;27, 2022 and additional proxy soliciting materials on
May 9, 2022 and June 1, 2022. Anika, its directors, its executive officers and certain other individuals set forth in the Proxy Statement,
as supplemented, will be deemed participants in the solicitation of proxies from stockholders in respect of the Annual Meeting. Information
regarding the names of Anika&rsquo;s directors and executive officers and certain other individuals and their respective interests in
Anika by security holdings or otherwise is set forth in the Proxy Statement. BEFORE MAKING ANY VOTING DECISION, STOCKHOLDERS ARE URGED
TO READ ALL RELEVANT DOCUMENTS FILED WITH OR FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION, INCLUDING THE PROXY STATEMENT, ALL SUPPLEMENTAL
MATERIALS THERETO AND THE ACCOMPANYING PROXY CARD. Stockholders may obtain copies of all documents filed by Anika with the Securities
and Exchange Commission in connection with the Annual Meeting, including the Proxy Statement, free of charge at the Securities and Exchange
Commission&rsquo;s website,&nbsp;www.sec.gov, or at https://ir.anika.com/annual-meeting or www.proxyvote.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  O /$# 2(  A$! Q$!_\0
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JD=3S^=>AT44ZDZ;O%A.G&:M)&5]EUO\ Z"MM_P" ?_V=%:M%+F'RG__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
